rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

530239 SUVEN Group (B)

Suven Life Sciences Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
23.75   0.90   3.94%
Volume 41,391
Prev close 22.85
Day's H/L (Rs.) 23.95 - 22.80
52wk H/L (Rs.) 35.25 - 13.75
Mkt Cap (Rs. Cr) 277.40
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

SUVEN

Suven Life Sciences Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
23.55   0.55   2.39%
Volume 94,979
Prev close 23.00
Day's H/L (Rs.) 23.90 - 22.80
52wk H/L (Rs.) 35.25 - 14.50
Turnover (Rs. Lacs) 22.19
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Realtime news for Suven Life Sciences Ltd. (See all 67 news)

19 June 2013, 11:56
Suven secures three product patents - 06 Jun 2013
Suven Life Sciences Board recommends Dividend of Rs. 0.30 for 2012-13 - 16 May 2013
Suven Life gets three patent products for CNS molecules - 10 May 2013
Suven Life Sciences jumps on securing three product patents for NCEs - 10 May 2013
Psychiatric Disorders Pipeline Review, H1 2013 - 2 day(s) ago

Market Voices for Suven Life Sciences Ltd.  (See all 35 market voices)   

140 Characters
  Cancel
Expert Voices - 14 May 2013
#Suven-Life-Sciences-Ltd
reports Q4 numbers with sales at Rs 74.7 crore vs Rs 62.9 crore, (YoY). (ET Now)
#Earnings
#money
Reply   |   Share
Kripa Shankar - 29 May 2013 oye yar its a really multibeggar company in future it would reach rs 500 in 3 years only.
#Suven-Life-Sciences-Ltd
#money
Reply   |   Share
harshad nimavat - 3 weeks ago  hi kripa
Reply   |  Share
harshad nimavat - 3 weeks ago  mai be usfda k bare me sab kuch janta hu or isme mera target bhi kafi badhiya hai ok rply
Reply   |  Share
harshad nimavat - 3 weeks ago  mau har dipp pe buy kar raha hu upar se news bhi kafi badhiya hai kya hn is bare mai baat kar sakte hai aap ka contact no ya fir face book reply....
Reply   |  Share

BSE Announcements from Suven Life Sciences Ltd. (See all)

Fixes Book Closure for Dividend and AGM - 14 May 2013
Financial Results with Results Press Release and Auditors Report for March 31, 2013 (Audited) - 14 May 2013

Company details for Suven Life Sciences Ltd.

Report Card

PE Ratios
8.68
EPS (Rs.)
2.64
Sales (Rs. Cr)
74.70
Face Value (Rs.)
1
Net Profit
Margin (%)
 
6.96
Last Bonus
1:1
Last Dividend(%)
30
Return on
Average Equity
 
11.26

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Suven Life Sciences Ltd. performance snapshot

If you had invested Rs.  in Suven Life Sciences Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Suven Life Sciences Ltd. with other stocks

Apollo Hospitals Enterprise Ltd.
987.70
Aurobindo Pharma Ltd.
180.60
Show more companies
Apollo Hospitals Enterprise Ltd.
987.70
Aurobindo Pharma Ltd.
180.60
Biocon Ltd.
277.10
Cadila Healthcare Ltd.
751.20
Cipla Ltd.
380.15
Divi's Laboratories Ltd.
966.40
Dr. Reddy's Laboratories Ltd.
2,146.55
GlaxoSmithKline Pharmaceuticals Ltd.
2,441.75
Glenmark Pharmaceuticals Ltd.
569.00
Ipca Laboratories Ltd.
671.45
Show less companies
Close
Add Suven Life Sciences Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Suven Life Sciences Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close